The pathologic role of autoantibodies in many autoimmune diseases is widely accepted. An enzyme immunoassay was used for measurement of antibodies against disease-specific antigens and etiologic agents for cross-reactive antigens associated with them. This antibody assay was applied to a panel of antigens for the detection of different neuroautoimmune diseases that included multiple sclerosis, motor peripheral neuropathies, multifocal motor neuropathy, amyotrophic lateral sclerosis and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection. We studied women with pregnancies complicated by neural tube defect, neuroborreliosis, autism and patients with possible somatic hypermutation. Antibodies were also measured against antigens and etiologic agents associated with primary biliary cirrhosis and chronic obstructive pulmonary disease. And, finally, antibodies were measured against several tumor antigens or peptides which are expressed in prostatic, breast and colon tissues. This panel of different autoantibodies was applied to 290 patients with neuroautoimmune disorders, cancer, and possible somatic hypermutation. The levels of these antibodies against different tissue-specific antigens and etiologic agents associated with them were significantly elevated in patients versus controls. We hope that this novel 96 antigen-specific ELISA will be used in additional studies that will prove its clinical efficacy, not only for the early diagnosis of many neuroautoimmune, liver and lung autoimmune disorders, but also for prognosis and the implementation of preventive steps for many complex diseases.
SteinmanL. Multiple sclerosis: a coordinated immunological attack against myelin in the nervous system. Cell1996; 85:299–302.
2.
RaineCSCannellaBHauserSLGenainCP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol1999; 46:144–60.
3.
WilsonNJBonifaceKChanJRMcKenzieBSBlumenscheinWMMattsonJDBashamBSmithKChenTMorelFLecronJCKasteleinRACuaDJMcClanahanTKBowmanEPde Waal MalefytR. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol2007; 8:950–7.
4.
StoneLASmithMEAlbertPSBashCNMaloniHFrankJAMcFarlandHF. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurol1995; 45: 1122–6.
5.
KimJVDustinML. Innate response to focal necrotic injury onside the blood-brain barrier. J Immunol2006; 177:5269–77.
6.
PharesTWFabisMJBrimerCMKeanRBHooperDC. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-α is neither necessary or sufficient. J Immunol2007; 178:7334–7343.
7.
KebirHKreymborgKIferganIDodelet-DevilersACayrolRBernardMGiulianiFArbourNBecherBPratA. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Med2007; 13:1173–6.
8.
AhmedSTsukaharaSTin-Tin-Win-ShweYamamotoSKunugitaNArashidaniKFujimakiH. Effects of low-level formaldehyde exposure on synaptic plasticity-related gene expression in hippocampus of immunized mice. J Neuroimmunol2007; 186:101–11.
9.
MissmerSASuarezLFelknerM. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect2006; 114:237–41.
10.
RothenbergSPda CostaMPSequeiraJM. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. New Engl J Med2004; 350:134–42.
11.
VojdaniAHebroniFRaphaelY. Novel diagnosis of Lyme disease: potential for CAM intervention. eCAM published online on 15 October 2007, doi:10.1093/ecam/nem138
12.
VojdaniAPangbornJBVojdaniECooperEL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol2003; 16(3): 189–99.
13.
LeungPSCParkOTsuneyamaK. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol2007; 179:2651–7.
14.
LeeSGoswamiSGurdoA. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nature Med2007; 13:567–9.
15.
KeoghEFikesJSouthwoodSCelisEChestnutRSetteA. Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity. J Immunol2001; 167:787–96.
16.
AllenSDGarrettJTRawaleSV. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo. J Immunol2002; 179:472–82.
17.
KotlanBSimsaPTeillaudJ-L. Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes. J Immunol2005; 175:2278–85.
18.
PennaGAmuchasteguiSCossettiC. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. J Immunol2007; 179:1559–67.
19.
SiegelSWagnerAFriedrichsB. Identification of HLA-A*0201-Presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies. J Immunol2006; 176:6935–44.
20.
SoussiT. P53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res2000; 60:1777–88.
21.
NilssonBOCarlssonLLarssonARonquistG. Autoantibodies to prostasomes as new markers for prostate cancer. Ups J Med Sci2001; 106:43–9.
22.
SoaresMMMehtaVFinOJ. Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection. J Immunol2001; 166:6555–63.
23.
WangXYuJSreekumarAVaramballySShenRGiacherioDMehraRMontieJEPientaKJSandaMGKantoffPWRubinMAWeiJTGhoshDChinnaiyanAM. Autoantibody signatures in prostate cancer. N Engl J Med2005; 353:1224–35.
24.
HsuHCWuYYangP. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol2007; 178:5357–65.
25.
VojdaniAVojdaniECooperEL. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, α-β-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Internal Med2003; 254:363–374.
26.
BergerTRubnerPSchnautzerF. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after first demyelinating event. N Engl J Med2003; 349:139–45.
27.
ChallonerPBSmithKTParkerJD. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA1995; 92:7440–4.
28.
TsunodaILibbeyJEFujinamiRS. Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol2007; 188:22–33.
29.
PatersonGWilsonGKennedyPGEWillisonHJ. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrate diverse V region gene usage with extensive somatic mutation. J Immunol1995; 155:3049–59.
30.
PeggyCGodschalkRKujifML. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infec Immun2007; 75:1245–54.
31.
RogersSWTwymanREGahringLC. The role of autoimmunity to glutamate receptors in neurological disease. Mol Med Today1996; 2:76–81.
32.
RakhitRRobertsonJVeldeCV. An immunological epitope selective for pathological monomer — misfolded SOD1 in ALS. Nature Med2007; 13:754–9.
33.
MellLKDavisRLOwensD. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatr2005; 116:56–60.
34.
KirvanCACoxCJSwedoSECunninghamMW. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol2007; 178:7412–21.
35.
Centers for Disease Control and Prevention. Recommendation for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR, Morb Mortal Wkly Rep1995; 44:590–591.
36.
EngstromSMShoopEJohnsonRC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol1995; 33:419–27.
37.
SequinPAllardACartierAMaloJL. Prevalence of occupational asthma in spray painters exposed to several types of isocyanates. J Occup Med1987; 29:340.
38.
NotkinsAL. New Predictor of diseases. Sci Am2007; 296:72–79.
39.
KuhleJPohlCMehlingM. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med2007; 356:371–8.
40.
PetersonLKTsunodaIMasakiTFujinamiRS. Polyreactive myelin oligodendrocyte glycoprotein antibodies: implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol2007; 183:69–80.
